Navigation Links
American Society for Microbiology honors Gene M. Shearer
Date:3/2/2010

The 2010 American Society for Microbiology (ASM) Abbott Laboratories Award in Clinical and Diagnostic Immunology is presented to Gene M. Shearer, Ph.D., Chief, Cell Mediated Immunity Section, Experimental Immunology Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, for his research on HIV pathogenesis. Sponsored by Abbott Laboratories' Diagnostics Division, this award recognizes a distinguished scientist in clinical or diagnostic immunology for outstanding contributions.

Shearer is renowned for his research on HIV pathogenesis. He received his Ph.D. from the University of Tennessee, Knoxville, and began his career at the NIH in 1972. During the AIDS epidemic, Shearer's research showed that the HIV infection leads to biologically important CD4+ T cell dysfunction prior to the loss of such cells and the onset of the clinical disease. His work showed the important role for immune dysregulation in HIV pathogenesis. Shearer defined the molecular mechanisms underlying such dysfunction and developed novel therapeutic approaches using HIV peptides to restore HIV specific immunity.

Shearer presumed that HIV averted immune destruction by initiating progression from a more protective TH1 response to a TH2 response and he was the first to grasp the importance of the innate immune response in control of HIV infection and the negative impact of interferon alpha. Recently, his work has shown that HIV drives immune activation and inflammation which promotes the development of AIDS and non-AIDS co morbidities. His insight have shaped our understanding of the immune response to HIV and has provided a focus for development of immune-based therapy and vaccines.

The Abbott Laboratories Award in Clinical and Diagnostic Immunology will be presented during the 110th General Meeting of the ASM, May 23-27, 2010 in San Diego, CA. ASM is the world's oldest and largest life science organization and has more than 43,000 members worldwide. ASM's mission is to advance the microbiological sciences and promote the use of scientific knowledge for improved health and economic and environmental well-being.


'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology
Source:Eurekalert

Related biology news :

1. American Society for Microbiology honors John J. Tudor
2. UAB study shows African-Americans have highest stroke rate, southerners more likely to die
3. Tips from the Journals of the American Society for Microbiology
4. Caltech receives more than $33 million from American Recovery and Reinvestment Act
5. Tips from the American Journal of Pathology
6. 78 scientists elected to the American Academy of Microbiology
7. According to new survey, Americans support strong climate, energy policies
8. American opinion cools on global warming
9. Tips from the American Journal of Pathology
10. St. Jude faculty member named American Association for the Advancement of Science 2009 Fellow
11. GenWay Clinical Laboratory receives accreditation from College of American Pathologists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
(Date:1/31/2017)...  Spero Therapeutics, LLC, a biopharmaceutical company founded ... bacterial infections, today announced it has acquired a ... Bono Bio Ltd (PBB) to bolster its pipeline ... of Gram-negative bacteria.   The assets acquired have been ... group company. "The acquisition of these ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... Fla. , Feb. 16, 2017  MDNA ... revolutionizing the development of liquid biopsy tests based ... entered into an exclusive license agreement with its ... MDNA,s proprietary liquid biopsy test for prostate cancer, ... South Korea . This is the first ...
(Date:2/16/2017)... Mass. , Feb. 16, 2017   Biostage, ... the "Company"), a biotechnology company developing bioengineered organ implants ... esophagus, bronchus and trachea, announced today the closing on ... of 20,000,000 shares of common stock and warrants to ... proceeds of $8.0 million. The offering was priced at ...
(Date:2/16/2017)... Feb. 16, 2017  Champions Oncology, Inc. (NASDAQ: ... and sale of advanced technology solutions and products to ... announced the addition of new cohorts of PDX models ... models will expand Champions, product line in hepatocellular cancer, ... cancer, AML, and non-small cell lung cancer (including EGFR ...
(Date:2/16/2017)... and NEW YORK , Feb. ... near completion of their $7M Series B financing, adding ... of the $3.5M led by Mesa Verde Venture Partners ... These resources will be directed towards further accelerating commercial ... a comprehensive genomic profiling test and expanding the Paradigm ...
Breaking Biology Technology: